Lundbeck poaches CSO from US biotech firm

Lundbeck has been on the prowl at US biotech company Immunitas Therapeutics, where it has found its new Head of Research with responsibility for drug discovery and early clinical development.
Future SVP and Head of Research at Lundbeck Tarek Samad | Photo: Lundbeck / PR
Future SVP and Head of Research at Lundbeck Tarek Samad | Photo: Lundbeck / PR
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY NIELSINE NIELSEN

Lundbeck has now found the person who will be in charge of accelerating the Danish pharmaceutical company's drug discovery and early clinical development research.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading